The Food and Drug Administration (FDA) has approved Kisqali, a breast cancer drug designed to treat advanced metastatic cases, for use in patients with earlier stage breast cancer. Novartis, the drug’s manufacturer, said that up to tens of thousands of women with early-stage breast cancer may get a new option that can help prevent their cancer
Loading
All posts in "Cancer News"
121A woman's risk of dying from breast cancer may be significantly decreased by following a plant-based, low-fat diet, especially if these better eating practices are started early on, before any cancerous symptoms show up.
A woman's risk of dying from breast cancer may be significantly decreased by following a plant-based, low-fat diet, especially if these better eating practices are started early on, before any cancerous symptoms show up.
120Breast Cancer recurrence is the cause of death for the majority of breast cancer patients. Finishing treatment can be an emotional milestone. But it’s often followed by worry over the future. 'OK, I’m done with treatment. … Now what?'”
Breast Cancer recurrence is the cause of death for the majority of breast cancer patients. Finishing treatment can be an emotional milestone. But it’s often followed by worry over the future. 'OK, I’m done with treatment. … Now what?'”
118The rising incidence of breast cancer in younger women is a complicated problem that probably involves a number of interrelated causes, including exposure to hormones, timing of reproduction, changes in lifestyle, and even environmental factors.
The rising incidence of breast cancer in younger women is a complicated problem that probably involves a number of interrelated causes, including exposure to hormones, timing of reproduction, changes in lifestyle, and even environmental factors.
117The rising incidence of breast cancer in younger women is a complicated problem that probably involves a number of interrelated causes, including exposure to hormones, timing of reproduction, changes in lifestyle, and even environmental factors.
The rising incidence of breast cancer in younger women is a complicated problem that probably involves a number of interrelated causes, including exposure to hormones, timing of reproduction, changes in lifestyle, and even environmental factors.
112Having dense breasts makes it harder to detect cancer through a mammogram, and dense tissue is also considered a risk factor for developing breast cancer.
Having dense breasts makes it harder to detect cancer through a mammogram, and dense tissue is also considered a risk factor for developing breast cancer.
110Black women have a much lesser breast cancer survival rates than white women, even from types that are typically thought to be treatable.
Black women have a much lesser breast cancer survival rates than white women, even from types that are typically thought to be treatable.
The Food and Drug Administration (FDA) has approved Kisqali, a breast cancer drug designed to treat advanced metastatic cases, for use in patients with earlier stage breast cancer. Novartis, the drug’s manufacturer, said that up to tens of thousands of women with early-stage breast cancer may get a new option that can help prevent their cancer
